Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Arpine Davtyan"'
Background:Prenatal diagnosis (preDx) of critical congenital heart disease (CCHD) decreases neonatal morbidity and mortality. Obstetrical fetal cardiac imaging guidelines in 2013 aimed to increase preDx. Objective: To determine the contemporary preDx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf30eb3fd33dd65ecdf83a1ce8928add
https://doi.org/10.21203/rs.3.rs-2843670/v1
https://doi.org/10.21203/rs.3.rs-2843670/v1
Publikováno v:
Heart Rhythm. 20:S437-S438
Autor:
Peter W, Guyon, Bassel, Mohammad Nijres, Henri, Justino, Arpine, Davtyan, Bryan, Mosher, Asimina, Courelli, Kanishka, Ratnayaka, John W, Moore, Howaida G, El-Said
Publikováno v:
The Journal of invasive cardiology. 33(12)
We report a multicenter experience with simultaneous right ventricular outflow tract (RVOT) stenting and transcatheter pulmonary valve implantation using the Melody valve (Medtronic).Prestenting the RVOT before Melody valve implantation is now the st
Autor:
Arpine Davtyan, Peter W. Guyon, Hannah R. El-Sabrout, Reid Ponder, Nanda Ramchandar, Rachel Weber, Wagih Zayed, Kanishka Ratnayaka, John J. Nigro, John W. Moore, Holly Bauser-Heaton, Laith Alshawabkeh, Ryan R. Reeves, Daniel Levi, Jamil Aboulhosn, Henri Justino, John Bradley, Howaida G. El-Said
Publikováno v:
Pediatric cardiology, vol 43, iss 4
Guidelines for management of Melody transcatheter pulmonary valve (TPV) infective endocarditis (IE) are lacking. We aimed to identify factors associated with surgical valve removal versus antimicrobial therapy in Melody TPV IE. Multicenter retrospect
Autor:
Arpine Davtyan, Michael G. Agadjanyan, Anahit Ghochikyan, Giselle F. Passos, Hayk Davtyan, David H. Cribbs, Irina Petrushina, Armine Hovakimyan
Publikováno v:
Molecular Therapy. 25:153-164
Previously, we reported that Alzheimer's disease (AD) epitope vaccines (EVs) composed of N-terminal β-amyloid (Aβ 42 ) B cell epitope fused with universal foreign T helper (Th) epitope(s) were immunogenic, potent, and safe in different amyloid prec
Autor:
Arpine Davtyan, Randy A. Albrecht, Annette M. Marleau, Adolfo García-Sastre, Anahit Ghochikyan, Michael G. Agadjanyan, Hayk Davtyan, Richard Cadagan, Armine Hovakimyan
Publikováno v:
Journal of Neuroimmunology. 277:77-84
Novel dual vaccine, WSN-Aβ 1–10 , based on the recombinant influenza virus, expressing immunodominant B-cell epitope of β-amyloid, simultaneously induced therapeutically potent anti-Aβ and anti-influenza antibodies. In this study we showed that
Autor:
Irina Petrushina, Vidya Murthy, David Agdashian, David H. Cribbs, Karen Zagorski, Hayk Davtyan, Michael G. Agadjanyan, Armine Hovakimyan, Anahit Ghochikyan, Arpine Davtyan
Publikováno v:
Current Gene Therapy. 14:190-199
DNA vaccines promote immune system activation in small animals and exhibit certain advantages when compared to conventional recombinant protein vaccines. However in clinical trials DNA vaccines are less effective in inducing potent immune responses d
Autor:
Arpine Davtyan, Hayk Davtyan, Irina Petrushina, Armine Hovakimyan, Michael G. Agadjanyan, David H. Cribbs, Anahit Ghochikyan
Publikováno v:
Alzheimer's & Dementia. 10:271-283
Background As a prelude to clinical trials we have characterized B- and T-cell immune responses in macaques to AD vaccine candidates: AV-1955 and its slightly modified version, AV-1959 (with 3 additional promiscuous Th epitopes). Methods T- and B-cel
Autor:
Anahit Ghochikyan, Michael G. Agadjanyan, Hayk Davtyan, Irina Petrushina, Arpine Davtyan, Tommy Saing, David H. Cribbs, Armine Hovakimyan
Publikováno v:
Neuroscience Letters. 560:86-91
Immunotherapeutic approaches reducing α-synuclein deposits may provide therapeutic benefit for Dementia with Lewy Bodies (DLB). Immunization with full-length human α-synuclein (hα-Syn) protein in a Parkinson's disease mouse model decreased the acc
Autor:
Claire F. Evans, Arpine Davtyan, Michael G. Agadjanyan, Armine Hovakimyan, Irina Petrushina, David H. Cribbs, Hayk Davtyan, Drew Hannaman, Anahit Ghochikyan
Publikováno v:
Alzheimer's & Dementia. 10:284-295
Background Clinical trials with passive and active Alzheimer's disease (AD) vaccines suggest that early interventions are needed for improvement of cognitive and/or functional performance in patients, providing impetus for the development of safe and